Trial Profile
A Clinical Trial on the Reduction of Bacteria (Including MRSA) in MRSA Positive Ulcers and Lesions
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Leg ulcer; Methicillin-resistant Staphylococcus aureus infections; Pressure ulcer
- Focus Therapeutic Use
- 20 Dec 2014 New trial record